KDM3A and liver cancer: Both the mRNA and protein levels of KDM3A were increased upon CEP131 overexpression, while knockdown of CEP131 reduced KDM3A expression, suggesting that KDM3A is also a downstream target of CEP131 in liver cancer cells (Fig. 6A, B).